The 6 analysts offering 12-month price forecasts for PMV Pharmaceuticals Inc have a median target of 41.00, with a high estimate of 63.00 and a low estimate of 25.00. The median estimate represents a +236.34% increase from the last price of 12.19.
The current consensus among 7 polled investment analysts is to Buy stock in PMV Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.42
Reporting Date Nov 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.